# ForteBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fortebio

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Website: www.fortebio.com
- Total disclosed funding: $42M
- Latest round: Series C (Sep 23, 2008)
- Investors on record: 7

## About

ForteBio is based in the US and operates as a life science company which develops analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction.

ForteBio is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences.

## Funding rounds

- Series C, Sep 23, 2008, $25M — Alloy Ventures, Latterell Venture Partners, OrbiMed Advisors, Versant Ventures, Vertical Group, MPM BioImpact
- Series B, Oct 26, 2005, $17M — Alloy Ventures, Latterell Venture Partners, Versant Ventures, Vertical Group, Agilent Ventures
- Series A, Jun 1, 2005 — Alloy Ventures, Latterell Venture Partners, Versant Ventures, Agilent Ventures

## Investors

- Alloy Ventures (https://capitalatlas.ai/funds/alloy-ventures) — Series A, Series B, Series C
- Latterell Venture Partners (https://capitalatlas.ai/funds/latterell-venture-partners) — Series A, Series B, Series C
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B, Series C
- Agilent Ventures (https://capitalatlas.ai/funds/agilent-ventures) — Series A, Series B
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series B, Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C